Navigation Links
Sam Rizk, MD, FACS, Named New York Magazine Best Doctor

New York, NY (PRWEB) September 02, 2013

According to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) rhinoplasty was the most popular procedure performed on both men and women under the age of 35. As common as the procedure is, rhinoplasty is among the most complex to perform because the surgeon must take into account not only aesthetics, but functional breathing considerations as well.

The nose is the most prominent feature on the human face, so even a small change can impact a person’s appearance in a big way. A beautiful nose is a natural one that complements and fits harmoniously with the other facial features.

Manhattan facial plastic surgeon Sam Rizk, MD, FACS, understands this delicate balance, striving to advance rhinoplasty techniques in order to achieve the most natural possible result, while optimizing patient satisfaction and comfort.

“With each rhinoplasty, I construct a natural looking nose grounded on the structure of the cartilage and the overlying skin that will stand the test of time,” says Dr. Rizk. “A natural nose should flow with the other facial features including the upper lip, chin, and cheeks. An important factor in achieving a result that doesn’t appear to have been altered is to maintain good structural support.”

Considered one of the best rhinoplasty surgeons in the world, Dr. Rizk has pioneered the use of high-definition three-dimensional endoscopic telescopes to better visualize the structures of the nose and perform a more precise surgery. The increased accuracy results in a more efficient procedure that requires no stitches, less bruising and scarring and one-third the recovery time of traditional surgeries.

The use of this system provides a precise view of the interior nasal area by inserting a telescope that is connected to an imaging system. With this enhanced view, Dr. Rizk can avoid disrupting blood vessels, muscles, and other sensitive tissues so there is less bruising and swelling, which promotes a quicker recovery. Because of increased visibility, the surgery is also more direct and allows for greater precision, as tissue is not distorted by swelling during the procedure.

Widely respected sought-after for his preeminent skill and leadership as one of New York’s best rhinoplasty surgeons, Dr. Rizk recently made the exclusive annual list of New York Magazine’s “Best Doctors.” The highly selective listing recognizes doctors who are the best in their field, taking into account not only professional qualifications and reputation (education, residency, board certification, hospital appointment, and disciplinary record) but also bed side manner and patient communications skills.

Dr. Rizk’s office is located at 1040 Park Avenue in Manhattan.

For more information on Sam Rizk, MD, FACS, visit

About Sam Rizk, MD, FACS
Sam Rizk, MD, FACS, is a double board certified New York City facial plastic surgeon and Director of Manhattan Facial Plastic Surgery, a JCAHO accredited surgical suite on Park Avenue. Dr. Rizk is a recognized expert on the latest advances and techniques in facial plastic surgery. He is a leader in secondary rhinoplasty, nasal reconstruction and repairing nasal defects for all skin types and ethnicities. Dr. Rizk has been selected for Castle Connolly's Best Doctors NY-Metro Area for Facial Plastic Surgery, and is a frequent presenter at AAFPRS, AACS, and FACE Ltd.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Top Rhinoplasty NYC Facial Plastic Surgeon Sam Rizk, MD, FACS, Sees Surge in Cosmetic Surgery Requests as a Result of Social Media
2. Facial Plastic Surgeon Sam Rizk, MD, FACS, Sees Spike in Neck Lifts in Manhattan Practice
3. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
4. Dr. William Oh named 2012 Legend of Neonatology
5. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
6. Old Bridge Sleep Center Named to Best of 2012 List
7. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
8. Pittsburgh Cardiologist Named Physician of the Year by Pulmonary Hypertension Association
9. IVR Technology Group Named Platimum VAR by TSYS
10. New coral reef crustacean described and named after late reggae performer Bob Marley
11. UT Southwestern named the official health care team of the Dallas Stars
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy ... and funds for Multiple System Atrophy (MSA) research, timed today to coincide with Giving ... things from patients including their ability to work and be productive, to do simple ...
(Date:12/1/2015)... ... 2015 , ... Henderson, a town of about 6,300 people, ... a partnership this year with Aeneas Internet and Telephone. , With faster Internet ... entrepreneurs who want to build a business. Whether startups or long established companies, ...
(Date:12/1/2015)... ... ... Integrated Rental Services (“Integrated Rental”), a growing medical equipment ... With support from JII, Integrated Rental is poised for expansion while improving its ... labs and medical facilities across the United States. , General Manager Robert Bean ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... ... , ... Dr. Paul Vitenas, one of the top cosmetic surgeons in ... as the Best Single Physician Practice in the nation. Dr. Vitenas and his practice ... by the industry publication. , Dr. Vitenas said he was very honored to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 01, 2015 ... the "Veterinary Equipment and Disposables Market by ... report to their offering. --> ... "Veterinary Equipment and Disposables Market by product, ... report to their offering. --> Research ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), ... commercialization of therapies for cardiovascular conditions via the inhalation ... business in Australia . InCarda is ... Australia in the first half ... and medical centers in Adelaide ...
Breaking Medicine Technology: